US Health Regulators Move to Ease Restrictions on Testosterone Therapy

In June 2026, the US Department of Health and Human Services directed the FDA to remove long-standing warning labels from testosterone products prescribed for age-related decline, citing updated safety evidence and aiming to give doctors clearer guid